Dangerous Work
By Editorial,
Nature
| 10. 02. 2013
Intelligence tests were first devised in the early twentieth century as a way to identify children who needed extra help in school. It was only later that the growing eugenics movement began to promote use of the tests to weed out the less intelligent and eliminate them from society, sparking a debate over the appropriateness of the study of intelligence that carries on to this day. But it was not the research that was problematic: it was the intended use of the results.
As the News Feature on
page 26 details, this history is never far from the minds of scientists who work in the most fraught areas of behavioural genetics. Although the ability to investigate the genetic factors that underlie the heritability of traits such as intelligence, violent behaviour, race and sexual orientation is new, arguments and attitudes about the significance of these traits are not. Scientists have a responsibility to do what they can to prevent abuses of their work, including the way it is communicated. Here are some pointers.
First: be patient. Do not speculate about the...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...